Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies

Clinical trial NCT04418661 · TERMINATED

Trial details

NCT number: NCT04418661
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Neoplasm

Start date: 2020-06-09
Primary completion: 2024-04-04
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.